期刊文献+

Immunohistochemical CD3 staining detects additional patients with celiac disease

Immunohistochemical CD3 staining detects additional patients with celiac disease
下载PDF
导出
摘要 AIM: To investigate whether performing immuno-histochemical CD3 staining, in order to improve the detection of intra-epithelial lymphocytosis, has an additional value in the histological diagnosis of celiac disease.METHODS: Biopsies obtained from 159 children were stained by hematoxylin and eosin(HE) and evaluated using the Marsh classification. CD3 staining was subsequently evaluated separately and independently.RESULTS: Differences in evaluation between the routine HE sections and CD3 staining were present in 20(12.6%) cases. In 10(6.3%) patients the diagnosis of celiac disease(Marsh Ⅱ and Ⅲ) changed on examination of CD3 staining: in 9 cases, celiac disease had initially been missed on the HE sections, while 1 patient had been over-diagnosed on the routine sections. In all patients, the final diagnosis based on CD3 staining, was concordant with serological results, which was not found previously. In the other 10(12.3%) patients, the detection of sole intra-epithelial lymphocytosis(Marsh Ⅰ) improved. Nine patients were found to have Marsh Ⅰ on CD3 sections, which had been missed on routine sections. Interestingly, the only patient with negative serology had Giardiasis. Finally, in 1 patient with negative serology, in whom Marsh Ⅰ was suspected on HE sections, this diagnosis was withdrawn after evaluation of the CD3 sections.CONCLUSION: Staining for CD3 has an additional value in the histological detection of celiac disease lesions, and CD3 staining should be performed when there is a discrepancy between serology and the diagnosis made on HE sections. AIM: To investigate whether performing immuno-histochemical CD3 staining, in order to improve the detection of intra-epithelial lymphocytosis, has an additional value in the histological diagnosis of celiac disease.METHODS: Biopsies obtained from 159 children were stained by hematoxylin and eosin(HE) and evaluated using the Marsh classification. CD3 staining was subsequently evaluated separately and independently.RESULTS: Differences in evaluation between the routine HE sections and CD3 staining were present in 20(12.6%) cases. In 10(6.3%) patients the diagnosis of celiac disease(Marsh Ⅱ and Ⅲ) changed on examination of CD3 staining: in 9 cases, celiac disease had initially been missed on the HE sections, while 1 patient had been over-diagnosed on the routine sections. In all patients, the final diagnosis based on CD3 staining, was concordant with serological results, which was not found previously. In the other 10(12.3%) patients, the detection of sole intra-epithelial lymphocytosis(Marsh Ⅰ) improved. Nine patients were found to have Marsh Ⅰ on CD3 sections, which had been missed on routine sections. Interestingly, the only patient with negative serology had Giardiasis. Finally, in 1 patient with negative serology, in whom Marsh Ⅰ was suspected on HE sections, this diagnosis was withdrawn after evaluation of the CD3 sections.CONCLUSION: Staining for CD3 has an additional value in the histological detection of celiac disease lesions, and CD3 staining should be performed when there is a discrepancy between serology and the diagnosis made on HE sections.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第24期7553-7557,共5页 世界胃肠病学杂志(英文版)
关键词 CELIAC disease Diagnosis Intra-epitheliallymphocytosis HISTOLOGY MARSH classification CD3staining Celiac disease Diagnosis Intra-epithelial lymphocytosis Histology Marsh classification CD3 staining
  • 相关文献

参考文献22

  • 1Mi M, Collin P. Coeliac disease. Lancet 1997; 349: 1755-1759[PMID: 9193393 DOI: 10.1016/S0140-6736(96)70237-4].
  • 2Marsh MN. Gluten, major histocompatibility complex, and thesmall intestine. A molecular and immunobiologic approach to thespectrum of gluten sensitivity eliac sprue-. Gastroenterology1992; 102: 330-354 [PMID: 1727768].
  • 3Grefte JM, Bouman JG, Grond J, Jansen W, Kleibeuker JH. Slowand incomplete histological and functional recovery in adult glutensensitive enteropathy. J Clin Pathol 1988; 41: 886-891 [PMID:3170777 DOI: 10.1136/jcp.41.8.886].
  • 4Rostom A, Dub-C, Cranney A, Saloojee N, Sy R, Garritty C,Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, MacNeil J,Mack D, Patel D, Moher D. The diagnostic accuracy of serologictests for celiac disease: a systematic review. Gastroenterology 2005;128: S38-S46 [PMID: 15825125 DOI: 10.1053/j.gastro.2005.02.028].
  • 5Husby S, Koletzko S, Korponay-Szab-IR, Mearin ML, PhillipsA, Shamir R, Troncone R, Giersiepen K, Branski D, Catassi C,Lelgeman M, Mi M, Ribes-Koninckx C, Ventura A, Zimmer KP.European Society for Pediatric Gastroenterology, Hepatology, andNutrition guidelines for the diagnosis of coeliac disease. J PediatrGastroenterol Nutr 2012; 54: 136-160 [PMID: 22197856 DOI:10.1097/MPG.0b013e31821a23d0].
  • 6Oahony S, Howdle PD, Losowsky MS. Review article:management of patients with non-responsive coeliac disease.Aliment Pharmacol Ther 1996; 10: 671-680 [PMID: 8899074 DOI:10.1046/j.1365-2036.1996.66237000.x].
  • 7Oberhuber G, Granditsch G, Vogelsang H. The histopathologyof coeliac disease: time for a standardized report scheme forpathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-1194[PMID: 10524652 DOI: 10.1097/00042737-199910000-00019].
  • 8Marsh MN, Loft DE, Garner VG, Gordon D. Time/dose responsesof celiac mucosae to graded oral challenges with Frazer fractionIII of gliadin. Eur J Gastroenterol Hepatol 1992; 4: 667-673.
  • 9Oberhuber G. Histopathology of celiac disease. Biomed Pharmacother2000; 54: 368-372 [PMID: 10989975 DOI: 10.1016/S0753-3322(01)80003-2].
  • 10United European Gastroenterology. When is a coeliac a coeliac-Report of a working group of the United European GastroenterologyWeek in Amsterdam, 2001. Eur J Gastroenterol Hepatol 2001; 13:1123-1128 [PMID: 11564968].

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部